Search frequency for Celltrion Healthcare, known as the exclusive distributor of Celltrion's biosimilars, has recently surged.

As of 11:30 AM on the 11th, Celltrion Healthcare's stock price rose 1.02% from the previous day to 108,600 KRW, with a trading volume of 955,187 shares, which is about 45.83% of the 5-day average trading volume. Today, foreigners have net purchased 47,893 shares of Celltrion Healthcare, and institutions have net purchased 2,000 shares, according to provisional data.

On August 10th, Celltrion Healthcare was a market topic with the headline "Rising trend expected from biosimilar benefits."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing